Open Access
| Issue |
BIO Web Conf.
Volume 214, 2026
The 2025 International Conference on Biomedical, Bioinformatics and Statistics (ICBBS 2025)
|
|
|---|---|---|
| Article Number | 01024 | |
| Number of page(s) | 5 | |
| Section | Biomedical, Bioinformatics and Statistics | |
| DOI | https://doi.org/10.1051/bioconf/202621401024 | |
| Published online | 02 February 2026 | |
- B. Routy, J.G. Lenehan, W.H. Miller, et al, Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat. Med. 29, 2121–2132 (2023). https://doi.org/10.1038/s41591-023-02453-x [Google Scholar]
- L. Chambers, D. Grencewicz, D. Spakowicz, From poo to promise: Fecal microbiota transplants support immunotherapy re-sensitization in solid tumors. Cell Host Microbe. 32, 1217–1218 (2024). https://doi.org/10.1016/j.chom.2024.07.015 [Google Scholar]
- M. Luu, Z. Riester, A. Baldrich, et al, Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat. Commun. 12, 4077 (2021). https://doi.org/10.1038/s41467-021-24331-1 [Google Scholar]
- A. Bachem, C. Makhlouf, K.J. Binger, et al, Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8(+) T Cells. Immunity 51, 285-297.e285 (2019). https://doi.org/10.1016/j.immuni.2019.06.002 [Google Scholar]
- X. Zhu, K. Li, G. Liu, et al, Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. Gut Microbes 15, 2249143 (2023). https://doi.org/10.1080/19490976.2023.2249143 [Google Scholar]
- Y. Yang, M. Ye, Y. Song, et al, Gut microbiota and SCFAs improve the treatment efficacy of chemotherapy and immunotherapy in NSCLC. npj Biofilms microbiotas 11, 146 (2025). https://doi.org/10.1038/s41522-025-00785-9 [Google Scholar]
- J.C. Baena, L.M. Pérez, A. Toro-Pedroza, et al, CAR T Cell Nanosymbionts: Revealing the Boundless Potential of a New Dyad. Int. J. Mol. Sci. 25 (2024). https://doi.org/10.3390/ijms252313157 [Google Scholar]
- D.A. Gaskarth, S. Fan, A.J. Highton, et al, The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity. Front Med (Lausanne) 12, 1577906 (2025). https://doi.org/10.3389/fmed.2025.1577906 [Google Scholar]
- M. Cazzaniga, M. Cardinali, F. Di Pierro, et al, The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588. Microorganisms 12 (2024). https://doi.org/10.3390/microorganisms12061235 [Google Scholar]
- P. Song, Z. Peng, X. Guo, Gut microbial metabolites in cancer therapy. Trends Endocrinol. Metab. 36, 55–69 (2025). https://doi.org/10.1016/j.tem.2024.06.016 [Google Scholar]
- P. Rangan, A. Mondino, Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy. J. ImmunoTher. Cancer 10 (2022). https://doi.org/10.1136/iitc-2021-004147 [Google Scholar]
- M. Huang, F. He, D. Li, et al, PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy. Cell Death Dis. 13, 931 (2022). https://doi.org/10.1038/s41419-022-05368-6 [Google Scholar]
- S. Lu, J. Li, Y. Li, et al, Succinate-loaded tumor cell-derived microparticles reprogram tumor-associated macrophage metabolism. Sci. Transl. Med. 17, eadr4458 (2025). https://doi.org/10.1126/scitranslmed.adr4458 [Google Scholar]
- X. Bai, Z. Duan, J. Deng, et al, Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism. J. Adv. Res. 72, 37–52 (2025). https://doi.org/10.1016/j.jare.2024.06.028 [Google Scholar]
- Z. Tao, Y. Chen, F. He, et al, Alterations in the Gut microbiota and Metabolisms in Pregnancies with Fetal Growth Restriction. Microbiol Spectr 11, e0007623 (2023). https://doi.org/10.1128/spectrum.00076-23 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.